| A |
| admin-023 |
Administrative Denials
|
September 01, 2021 |
May 26, 2021 |
May 26, 2022 |
| D |
| admin-021 |
Dismissal: Failure to Follow Filing Procedures
|
July 1, 2021 |
May 26, 2021 |
May 26, 2022 |
| mp-026 |
Drug Levels and Antibody Testing for Infliximab, Adalimumab, Vedolizumab and Ustekinumab
|
September 20, 2021 |
July 15, 2021 |
July 15, 2022 |
| reimb-030 |
Durable Medical Equipment (DME)
|
October 06, 2021 |
August 06, 2021 |
August 06, 2022 |
| G |
| mp-045 |
General Policy for Genetic Testing
|
August 23, 2021 |
June 23, 2021 |
June 23, 2022 |
| I |
| MP-068 |
Intraosseous Basivertebral Nerve Ablation Procedure (Intracept)
|
August 23, 2021 |
June 23, 2021 |
June 23, 2022 |
| M |
| reimb-034 |
Multiple Procedure Payment Reduction (MPPR)
|
September 01, 2021 |
July 01, 2021 |
July 01, 2022 |
| N |
| reimb-007 |
Next Generation Sequencing (NGS) Genetic Testing
|
October 06, 2021 |
August 6, 2021 |
August 06, 2022 |
| P |
| reimb-026 |
Prolonged Services
|
September 01, 2021 |
May 19, 2021 |
May 19, 2022 |
| R |
| admin-022 |
Retrospective Service Reviews
|
September 01, 2021 |
May 26, 2021 |
May 26, 2022 |
